These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9399964)

  • 21. Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs.
    Suryawan A; Nguyen HV; Bush JA; Davis TA
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E908-15. PubMed ID: 11595645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phosphatidylinositol/AKT/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo.
    Campbell CS; Caperuto LC; Hirata AE; Araujo EP; Velloso LA; Saad MJ; Carvalho CR
    Life Sci; 2004 Nov; 76(1):57-70. PubMed ID: 15501480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
    Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
    Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
    Saad MJ; Folli F; Araki E; Hashimoto N; Csermely P; Kahn CR
    Mol Endocrinol; 1994 May; 8(5):545-57. PubMed ID: 7520127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
    Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
    Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation.
    Zhang Q; Carter EA; Ma BY; White M; Fischman AJ; Tompkins RG
    Life Sci; 2005 Oct; 77(24):3068-77. PubMed ID: 15982669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased gene expression of insulin signaling genes in insulin sensitive tissues of obese cats.
    Mori A; Lee P; Takemitsu H; Iwasaki E; Kimura N; Yagishita M; Hayasaka M; Arai T
    Vet Res Commun; 2009 Apr; 33(4):315-29. PubMed ID: 18946721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term denervation impairs insulin receptor substrate-1-mediated insulin signaling in skeletal muscle.
    Hirose M; Kaneki M; Sugita H; Yasuhara S; Ibebunjo C; Martyn JA
    Metabolism; 2001 Feb; 50(2):216-22. PubMed ID: 11229432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.
    Egawa K; Nakashima N; Sharma PM; Maegawa H; Nagai Y; Kashiwagi A; Kikkawa R; Olefsky JM
    Endocrinology; 2000 Jun; 141(6):1930-5. PubMed ID: 10830273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.
    Standaert ML; Sajan MP; Miura A; Kanoh Y; Chen HC; Farese RV; Farese RV
    J Biol Chem; 2004 Jun; 279(24):24929-34. PubMed ID: 15069067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of IRS-2 causes type 2 diabetes in mice.
    Withers DJ; Gutierrez JS; Towery H; Burks DJ; Ren JM; Previs S; Zhang Y; Bernal D; Pons S; Shulman GI; Bonner-Weir S; White MF
    Nature; 1998 Feb; 391(6670):900-4. PubMed ID: 9495343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
    Goodyear LJ; Giorgino F; Sherman LA; Carey J; Smith RJ; Dohm GL
    J Clin Invest; 1995 May; 95(5):2195-204. PubMed ID: 7537758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dwarf mutation decreases high dose insulin responses in skeletal muscle, the opposite of effects in liver.
    Dominici FP; Argentino DP; Bartke A; Turyn D
    Mech Ageing Dev; 2003 Jul; 124(7):819-27. PubMed ID: 12875745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
    Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR
    Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
    Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
    Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
    Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of insulin resistance.
    Saad MJ
    Braz J Med Biol Res; 1994 Apr; 27(4):941-57. PubMed ID: 8087096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.